Literature DB >> 26888788

Impact of triggering event in outcomes of stress-induced (Takotsubo) cardiomyopathy.

Charan Yerasi1, Edward Koifman1, Gaby Weissman1, Zuyue Wang1, Rebecca Torguson1, Jiaxiang Gai1, Joseph Lindsay1, Lowell F Satler1, Augusto D Pichard1, Ron Waksman1, Itsik Ben-Dor1.   

Abstract

BACKGROUND: Takotsubo syndrome is also known as stress cardiomyopathy because of the regularity with which it has been associated with physical or emotional stress. Such stress may well be a "trigger" of the syndrome. AIMS: This analysis was undertaken to describe our experience with this disorder and in particular to examine the effects of the underlying trigger on outcomes.
METHODS: We conducted a retrospective review of the medical records of 345 consecutive patients treated at our institution from 2006 to 2014. All presented with acute cardiac symptoms, a characteristic left ventricular contraction pattern (typical, atypical), and no major obstructive coronary artery disease. Patients were grouped based on their triggering event: (a) medical illness; (b) post-operative period; (c) emotional distress; or (d) no identified trigger. Baseline demographic characteristics, death in hospital, length of stay in hospital, and cardiac complications were abstracted from the patients' medical records.
RESULTS: The mean±SD age of the population was 72±12 years and 91% were women. No significant difference in baseline characteristics was noted between the groups except for a higher prevalence of African Americans in the group with a medical illness. ST elevation was noted in 13.3% of patients and the average peak troponin level was 5±12 ng/dl. An inotropic drug was required in 49 (14.2%) patients, an intra-aortic balloon pump in 37 (10.7%) patients, and mechanical ventilation in 54 (15.7%) patients; 43.5% required treatment in the intensive care unit. Overall, 12 (3.5%) patients died. In only two (16.7%) patients was a there a direct cardiac cause of death. In those patients in whom the cardiac manifestations seemed to be triggered by a medical illness, the death rate was 7.1% and this was significantly higher than in the other groups ( p=0.03). Medical illness (odds ratio=6.25, p=0.02) and ST elevation (odds ratio=5.71, p=0.04) were both significantly associated with death.
CONCLUSIONS: Our study showed that different triggers for Takotsubo syndrome confer different prognoses, with medical illness conferring the worst prognosis. Overall, the in-hospital death rate was low and mostly related to non-cardiac death secondary to the underlying medical illness. Although an unidentified trigger was prevalent in a third of this population, efforts should be made to identify the triggering event to classify the risk group of patients with Takotsubo syndrome.

Entities:  

Keywords:  Takotsubo cardiomyopathy; mortality; outcomes; triggers

Mesh:

Substances:

Year:  2016        PMID: 26888788     DOI: 10.1177/2048872616633881

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  5 in total

1.  Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine.

Authors:  Tara Burleigh; Birgit Khandalavala
Journal:  Eur J Case Rep Intern Med       Date:  2020-05-04

Review 2.  Advanced Imaging and Diagnostic Methods in the Assessment of Suspected Ischemic Heart Disease in Women.

Authors:  Joanna M Joly; Vera Bittner
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

3.  Possible predictive factors for recovery of left ventricular systolic function in Takotsubo cardiomyopathy.

Authors:  Nasreen Shaikh; Muhammad Sardar; Aasems Jacob; Sayee Sundar Alagusundaramoorthy; Margaret Eng; John Checton; Ajay Shah
Journal:  Intractable Rare Dis Res       Date:  2018-05

4.  Clinical features of patients with septic shock-triggered Takotsubo syndrome: a single-center 7 case series.

Authors:  Chengqiao Jing; Yan Wang; Chunmiao Kang; Daoran Dong; Yuan Zong
Journal:  BMC Cardiovasc Disord       Date:  2022-07-29       Impact factor: 2.174

5.  Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis.

Authors:  Ekaterina S Prokudina; Boris K Kurbatov; Konstantin V Zavadovsky; Alexander V Vrublevsky; Natalia V Naryzhnaya; Yuri B Lishmanov; Leonid N Maslov; Peter R Oeltgen
Journal:  Curr Cardiol Rev       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.